IBX.AX

Healthcare Diagnostics & Research

Imagion Biosystems Limited

A$0.01

+0.00 +0.00% today Live

Price History

Not enough data

Price chart data
Date	Price
Oct 5, 2026, live at 12:13 PM ET	0.01

Key Stats

Market Cap

5.61M

Avg Volume

1.83M

EPS

-A$0.01

52W High

A$0.04

52W Low

A$0.01

Div. Yield

0.0%

Valuation

P/B Ratio

-1.17

P/S Ratio

9.78

EV/EBITDA

-1.45

EV/Revenue

10.36

Margins

Gross Margin 0.0%

Operating Margin (331.4%)

Net Margin 0.0%

EBITDA Margin 0.0%

Growth & Returns

Revenue Growth (YoY)

1943.7%

Return on Assets

(319.7%)

Liquidity & Leverage

Current Ratio

0.16

Quick Ratio

0.15

Total Cash

32,456

Total Debt

2.19M

About

Imagion Biosystems Limited operates as a medical imaging company that uses bio-safe magnetic nanoparticles to detect cancer and other diseases in Australia. The company is involved in nanotechnology; biotechnology; medical imaging using magnetic resonance; and cancer diagnostics businesses. It develops MagSense, which is in Phase 2 for the treatment of HER2 breast cancers, as well as advancing the research and development programs for prostate and ovarian cancer. It also develops PrecisionMRX, an iron oxide nanoparticle to magnetic relaxometry. The company has collaboration agreement with Wayne State University to develop optimised MRI sequences which is in Phase 2 study of for the MagSense imaging agent. Imagion Biosystems Limited was incorporated in 2016 and is based in Melbourne, Australia.

imagionbiosystems.com